NLRP3 and diabetes mellitus: In the hyperglycemic environment, the increase in NLRP3 inflammasome-dependent IL-1β secretion leads to the dysfunction of insulin secretion of β cells, promotes obesity and insulin resistance, and eventually leads to diabetes (Iannantuoni et al., 2019).